Europe Microfluidics Market

Market Introduction

Microfluidics involves processing or manipulation of small amount of fluidics. It studies various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. Microfluidics is an emerging technology having a wide range of applications in biology, chemistry, optics and information technology. This technology is widely used for various processes such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, PCR amplification, among others. Additionally, microfluidics is also used in the diagnosis of diseases such as cancer and research.

Market Overview and Dynamics

The Europe Microfluidics market is expected to reach US$ 12,827.36 million in 2027 from US$ 3,625.15 million in 2019. The market is anticipated to grow with a CAGR of 17.4% from 2020 to 2027. Factors driving the market growth include adoption of microfluidics technologies in point-of-care testing, and advancement in microfluidics products. However, regulatory approval process is the major factor hindering the market growth. COVID19 has affected the European countries which has led to high number of coronavirus cases. Many key players are launching product for detection of coronavirus.

Key Market Segments

In terms of product, the device segment held the largest share of the market in 2019; however, the microfluidic chips segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of material, the PDMS segment held a larger share of the market in 2019 and similar segment is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of application, the in vitro diagnostics segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.

Major Sources and Companies Listed

The World Health Organization (WHO), World Heart Federation, European Medical Association, National Center for Biotechnology Information are some of the major primary and secondary sources for the Europe Microfluidics market included in the report.

Reasons to buy the report

• To understand the Europe Microfluidics market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe Microfluidics  market
• Efficiently plan M&A and partnership deals in the Europe Microfluidics market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the Europe Microfluidics market
• Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

Europe Microfluidics Market Segmentation

Microfluidics Market – By Product

• Devices
• Microfluidic Chips
• Microfluidic Sensors
• Micropumps
• Microneedles
• Other Products

Microfluidics Market – By Material

• PDMS
• Glass
• Silicon
• Polymer
• Other Materials

Microfluidics Market – By Application

• In Vitro Diagnostics
  • Point-of-Care Testing
  • Clinical Diagnostics
• Pharmaceutical and Life Science Research
• Drug Discovery
• Other Applications

Company Profiles

• Agilent Technologies, Inc.,
• BD
• Bio-Rad Laboratories Inc.
• Danaher
• Dolomite Microfluidics (Blacktrace Holdings Ltd.)
• Fludigm Corporation
• Illumina, Inc.
• microfluidic ChipShop GmbH,
• Perkin Elmer, Inc.
• Thermo Fisher Scientific Inc.

Europe Microfluidics Market Strategic Insights

Europe Microfluidics Market Segmentation Analysis

Europe Microfluidics Market Report Highlights

Europe Microfluidics Report Scope

Europe Microfluidics Market Country and Regional Insights